Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: EIF3A[original query] |
---|
Association between eIF3a polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients. British journal of clinical pharmacology 2013 Feb 75 (2): 516-23. Xu Xiaojing, Han Lifang, Duan Li, Zhao Yingchun, Yang Huaping, Zhou Boting, Ma Rui, Yuan Ruixia, Zhou Honghao, Liu Zhaoqi |
The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients. Lung cancer (Amsterdam, Netherlands) 2012 Nov . Xu X, Han L, Yang H, Duan L, Zhou B, Zhao Y, Qu J, Ma R, Zhou H, Liu Z |
Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients. Acta pharmacologica Sinica 2015 Mar 36 (3): 375-84. Yin Ji-ye, Meng Xiang-guang, Qian Chen-yue, Li Xiang-ping, Chen Juan, Zheng Yi, Liu Rong, Zhou Hong-hao, Liu Zhao-qi |
Impact of a Eukaryotic Translation Initiation Factor 3a Polymorphism on Susceptibility to Gastric Cancer. Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2016 Jun . Liu Kuijie, Lei Zhendong, Yao Hongliang, Lei Sanlin, Zhao H |
The eIF3a Arg803Lys genetic polymorphism is associated with susceptibility to and chemoradiotherapy efficacy in cervical carcinoma. The Kaohsiung journal of medical sciences 2017 Apr 33 (4): 187-194. Xu Jia-Zhen, Wen Fang, Wang Xian-Ro |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: